Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Acq. announced
Appointed director
CC transcript
Asset disposition
Inv. presentation
Director departure
|
|
HOLOGIC INC (HOLX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/06/2020 |
8-K
| Asset disposition|
Docs:
|
"Hologic Completes Divestiture of Cynosure Medical Aesthetics Business",
"Hologic, Inc. UNAUDITED PRO FORMA CONDENSED CONSOLIDATED FINANCIAL INFORMATION On December 30, 2019, Hologic, Inc. completed the sale of its Medical Aesthetics business to an affiliate of investment funds managed by Clayton, Dubilier & Rice, LLC . The Medical Aesthetics business offers a portfolio of aesthetic treatment systems, including SculpSure, PicoSure, MonaLisa Touch and TempSure that enable plastic surgeons, dermatologists and other medical practitioners to perform non-invasive and minimally invasive procedures to remove hair, treat vascular and benign pigmented lesions, remove multi-colored tattoos, revitalize the skin, reduce fat through laser lipolysis, reduce cellulite, clear nails infected by toe fungus, ablate sweat glands, improve gynecologic health and use a radio frequency..." |
|
| 02/02/2017 |
8-K
| Form 8-K - Current report |
|
|